A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

Clinical trial NCT03347370 · COMPLETED

Trial details

NCT number: NCT03347370
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2017-11-27
Primary completion: 2019-07-31
Enrollment: 626

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.